Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.etrials Worldwide names new VP of technology and development
Previously, Dr Emerson has served as director of computer resources at KPMG in its New York executive office; vice president of technology at Pansophic Systems; president of RTI
Previously, Dr Emerson has served as director of computer resources at KPMG in its New York executive office; vice president of technology at Pansophic Systems; president of RTI
The acquired business includes tests sold within Inverness’s focus areas of infectious disease, cardiology, drugs of abuse and women’s health. In March 2006, Inverness acquired Acon’s rapid diagnostics
Allos Therapeutics, a biopharmaceutical company, has reported that the European Medicines Agency, with a positive opinion of the Committee for Orphan Medicinal Products, has granted orphan medicinal product
The two centers generate approximately $5.6 million in annual revenues. One center is exclusively magnetic resonance imaging (MRI) while the other is a multi-modality facility. The acquisition is
BioNanomatrix, a developer of nanoscale platforms for biomedical research, molecular diagnostics and personalized medicine, has received a Phase II grant from the National Human Genome Research Institute of
Under the terms of the agreement, Lipoxen will provide Glide Pharma with SuliXen which Glide Pharma will then incorporate into its proprietary Glide SDI, needle-free, drug delivery technology
Cortex will focus its efforts on the development of its clinical programs involving CX717 and CX1739, which it believes will have the greatest opportunity for creation of shareholder
Synta Pharmaceuticals, a developer and marketer of small molecule drugs, has treated the first patient in a Phase I/II clinical study of STA-9090, a novel heat shock protein
Oxygen Biotherapeutics, a developer of biotechnology products, has announced that the company will move ahead with a line of gels based on Oxycyte. The first and most basic
US-based UnitedHealthcare’s Golden Rule Insurance Company has introduced new coverage options to reportedly help make dental and vision care more affordable for consumers in 15 states and the